Sole US Patent Protecting Apriso Mesalamine Capsules Is Obvious

 
• By Aidan Fry
  
Obvious
The sole listed US patent against Bausch's Apriso mesalamine capsules is obvious • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin